Follow
john mchutchison
john mchutchison
Verified email at gilead.com
Title
Cited by
Cited by
Year
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
MP Manns, JG McHutchison, SC Gordon, VK Rustgi, M Shiffman, ...
The Lancet 358 (9286), 958-965, 2001
82922001
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
JG McHutchison, SC Gordon, ER Schiff, ML Shiffman, WM Lee, VK Rustgi, ...
New England Journal of Medicine 339 (21), 1485-1492, 1998
45531998
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
D Ge, J Fellay, AJ Thompson, JS Simon, KV Shianna, TJ Urban, ...
Nature 461 (7262), 399-401, 2009
44982009
Telaprevir for previously untreated chronic hepatitis C virus infection
IM Jacobson, JG McHutchison, G Dusheiko, AM Di Bisceglie, KR Reddy, ...
New England Journal of Medicine 364 (25), 2405-2416, 2011
32582011
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
DL Thomas, CL Thio, MP Martin, Y Qi, D Ge, C O’hUigin, J Kidd, K Kidd, ...
Nature 461 (7265), 798-801, 2009
26912009
Sofosbuvir for previously untreated chronic hepatitis C infection
E Lawitz, A Mangia, D Wyles, M Rodriguez-Torres, T Hassanein, ...
New England Journal of Medicine 368 (20), 1878-1887, 2013
24032013
Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection
N Afdhal, S Zeuzem, P Kwo, M Chojkier, N Gitlin, M Puoti, ...
New England Journal of Medicine 370 (20), 1889-1898, 2014
21462014
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
P Marcellin, E Gane, M Buti, N Afdhal, W Sievert, IM Jacobson, ...
The Lancet 381 (9865), 468-475, 2013
19912013
Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection
JG McHutchison, EJ Lawitz, ML Shiffman, AJ Muir, GW Galler, J McCone, ...
New England Journal of Medicine 361 (6), 580-593, 2009
17882009
Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection
N Afdhal, KR Reddy, DR Nelson, E Lawitz, SC Gordon, E Schiff, ...
New England Journal of Medicine 370 (16), 1483-1493, 2014
17042014
Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis
KV Kowdley, SC Gordon, KR Reddy, L Rossaro, DE Bernstein, E Lawitz, ...
New England Journal of Medicine 370 (20), 1879-1888, 2014
14892014
Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C
T Poynard, J McHutchison, M Manns, C Trepo, K Lindsay, Z Goodman, ...
Gastroenterology 122 (5), 1303-1313, 2002
14632002
Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options
IM Jacobson, SC Gordon, KV Kowdley, EM Yoshida, M Rodriguez-Torres, ...
New England journal of medicine 368 (20), 1867-1877, 2013
14162013
Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection
JG McHutchison, GT Everson, SC Gordon, IM Jacobson, M Sulkowski, ...
New England Journal of Medicine 360 (18), 1827-1838, 2009
14122009
Adherence to combination therapy enhances sustained response in genotype-1–infected patients with chronic hepatitis C
JG McHutchison, M Manns, K Patel, T Poynard, KL Lindsay, C Trepo, ...
Gastroenterology 123 (4), 1061-1069, 2002
13242002
Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection
JJ Feld, IM Jacobson, C Hézode, T Asselah, PJ Ruane, N Gruener, ...
New England Journal of Medicine 373 (27), 2599-2607, 2015
13092015
Telbivudine versus lamivudine in patients with chronic hepatitis B
CL Lai, E Gane, YF Liaw, CW Hsu, S Thongsawat, Y Wang, Y Chen, ...
New England Journal of Medicine 357 (25), 2576-2588, 2007
11722007
Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C
GL Davis, JB Wong, JG McHutchison, MP Manns, J Harvey, J Albrecht
Hepatology 38 (3), 645-652, 2003
11422003
Sofosbuvir and velpatasvir for HCV genotype 2 and 3 infection
GR Foster, N Afdhal, SK Roberts, N Bräu, EJ Gane, S Pianko, E Lawitz, ...
New England Journal of Medicine 373 (27), 2608-2617, 2015
10352015
Sofosbuvir and ribavirin in HCV genotypes 2 and 3
S Zeuzem, GM Dusheiko, R Salupere, A Mangia, R Flisiak, RH Hyland, ...
New England Journal of Medicine 370 (21), 1993-2001, 2014
10182014
The system can't perform the operation now. Try again later.
Articles 1–20